Art. 63 Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 20…

In forcesince 31 Mar 2004cited 11×
1.

The membership of the committees referred to in Article 56(1) shall be made public. When each appointment is published, the professional qualifications of each member shall be specified.

2.

Members of the Management Board, members of the committees, rapporteurs and experts shall not have financial or other interests in the pharmaceutical industry which could affect their impartiality. They shall undertake to act in the public interest and in an independent manner, and shall make an annual declaration of their financial interests. All indirect interests which could relate to this industry shall be entered in a register held by the Agency which is accessible to the public, on request, at the Agency's offices.

The Agency's code of conduct shall provide for the implementation of this Article with particular reference to the acceptance of gifts.

Members of the Management Board, members of the committees, rapporteurs and experts who participate in meetings or working groups of the Agency shall declare, at each meeting, any specific interests which could be considered to be prejudicial to their independence with respect to the items on the agenda. These declarations shall be made available to the public.

The 10 that are cited most themselves, of 11.

  • Directive (EU) 2001/8327Law

    … на назначените членове на координационната група и експерти. Член 63 от Регламент (ЕО) № 726/2004 се прилага за координационната група …

  • Judgment of the General Court (Sixth Chamber) of 28 October 2020. Pharma Mar, SA v European Commission.Decision

    First of all, it should be noted that, under Article 63(2) of Regulation No 726/2004: ‘Members of the Management Board, members of the committees, rapporteurs and experts shall not have financial or other interests in the pharmaceutical …

    28 Oct 2020 · 62018TJ0594

  • Judgment of the Court (Third Chamber) of 22 June 2023. Federal Republic of Germany v European Commission.Decision

    Title IV of Regulation No 726/2004, entitled ‘The European Medicines Agency – Responsibilities and administrative structure’, includes a Chapter 1, itself entitled ‘Tasks of the agency’, comprising Articles 55 to 66 of that same …

    22 Jun 2023 · 62021CJ0006

  • Arrêt du Tribunal (huitième chambre) du 2 mars 2022. Debregeas et associés Pharma (D & A Pharma) contre Commission européenne et Agence euroDecision

    À cet égard, il convient d’observer que l’article 63, paragraphe 2, du règlement n o 726/2004 prévoit que « [l]es membres du conseil d’administration, les membres des comités, les rapporteurs et les experts ne peuvent pas avoir …

    2 Mar 2022 · 62020TJ0556

  • Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 Novembe…22Law

    В допълнение към изискванията, установени в член 63 от Регламент (ЕО) № 726/2004, членовете и заместниците на Комитета за модерни …

  • Directive (EU) 2010/841Law

    … на назначените членове на координационната група и експерти. Член 63 от Регламент (ЕО) № 726/2004 се прилага за координационната група …

  • Judgment of the Court (Fourth Chamber) of 14 March 2024. Debregeas et associés Pharma (D & A Pharma) v European Commission and European MediDecision

    Under Article 63(2) of Regulation No 726/2004: ‘Members of the Management Board, members of the committees, rapporteurs and experts shall not have financial or other interests in the pharmaceutical industry which could affect their …

    14 Mar 2024 · 62022CJ0291

  • Regulation (EU) 2022/1231532Law

    … на Работната група за извънредните ситуации се прилага член 63 от Регламент (ЕО) № 726/2004. 9. Агенцията публикува на своя интернет …

  • Opinion of Advocate General Medina delivered on 7 September 2023. Debregeas et associés Pharma (D & A Pharma) v European Commission and EuroDecision

    In paragraphs 93 to 96 of the judgment under appeal, the General Court recalled the wording of Article 63(2) of Regulation No 726/2004 and noted that, in accordance with that provision, the EMA adopted the policy of 6 October 2016, …

    7 Sep 2023 · 62022CC0291

  • Opinion of Advocate General Richard de la Tour delivered on 12 January 2023.Decision

    … Всъщност, както тя припомня в писменото си становище, член 63, параграф 2 от Регламент № 726/2004, който оправомощава ЕМА да изготви …

    12 Jan 2023 · 62021CC0006